Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Synthetic Biology
Investigating a Novel Bacterial Form for Biological Computers
A novel method of computational biology using colonies of bacteria has been developed by researchers at University College London.
Spatial Analysis
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
Genomic Biomarkers
ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers
The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.
Genome Editing
Functional Genomics Reveals Major Cause of Inflammatory Bowel Disease, Discovered by UK Scientists
Genomics helped the UK-based team track down a gene that, when over expressed, was significantly responsible for causing IBD.
Clinical Diagnostics
FDA Advisors Back Guardant Health's Colorectal Cancer Blood Test
Although colonoscopy is definitively the most effective method of colorectal cancer diagnosis, the blood test is "better than nothing."
Genomic Biomarkers
Hope for New Prognostic Biomarkers & Therapeutic Options From Tumour Metabolism-Targeting Breast Cancer Study
Understanding the interplay between the tumour microenvironment and immunometabolic states could unlock a wealth of therapeutic targets and biomarkers.